Page last updated: 2024-12-07

n-benzylglucamine dithiocarbamate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-benzylglucamine dithiocarbamate: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID105107
MeSH IDM0140124

Synonyms (14)

Synonym
nbg-dtc
n-benzyl-n-dithiocarboxy-d-glucamine
n-benzylglucamine dithiocarbamate
bgdtc
benzylglucamine-n-carbodithioate
n-benzyl-d-glucamine dithiocarbamate
d-glucitol, 1-deoxy-1-((dithiocarboxy)(phenylmethyl)amino)-
110771-92-1
benzyl-[(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl]carbamodithioic acid
unii-m0ou990u9p
m0ou990u9p ,
1-[benzyl(sulfanylcarbonothioyl)amino]-1-deoxyhexitol
DTXSID90911858
Q27283308

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" A dose-response study was made of the mobilization of cadmium from the liver and kidney of cadmium-loaded mice by NaB; this showed that NaB is one of the most effective cadmium mobilizing agents developed to date."( Meso-2,3-dimercaptosuccinic acid and sodium N-benzyl-N-dithiocarboxy-D-glucamine as antagonists for cadmium intoxication.
Basinger, MA; Gale, GR; Holscher, MA; Jones, MM; Jones, SG; Topping, RJ, 1988
)
0.27
" Compared to BGDTC, the new compounds were, except at the highest dosage studied, equally or more effective in decreasing retention of hepatic cadmium, while mostly less effective in decreasing renal cadmium."( Meso-2,3-dimercaptosuccinic acid mono-N-alkylamides: syntheses and biological activity as novel in vivo cadmium mobilizing agents.
Blanusa, M; Jones, MM; Piasek, M; Restek-Samarzija, N; Rostial, K; Singh, PK, 1996
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (41)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (24.39)18.7374
1990's29 (70.73)18.2507
2000's2 (4.88)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.66 (24.57)
Research Supply Index3.87 (2.92)
Research Growth Index4.53 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other47 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]